2/9
04:05 pm
qncx
Quince Therapeutics Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Alternatives
High
Report
Quince Therapeutics Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Alternatives
2/3
07:12 am
qncx
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Maxim Group from a "strong-buy" rating to a "hold" rating.
High
Report
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Maxim Group from a "strong-buy" rating to a "hold" rating.
1/31
07:46 am
qncx
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Brookline Capital Management from a "strong-buy" rating to a "hold" rating.
High
Report
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Brookline Capital Management from a "strong-buy" rating to a "hold" rating.
1/31
07:46 am
qncx
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
High
Report
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at D Boral Capital from a "strong-buy" rating to a "hold" rating.
1/31
07:46 am
qncx
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Lucid Cap Mkts from a "strong-buy" rating to a "strong sell" rating.
High
Report
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Lucid Cap Mkts from a "strong-buy" rating to a "strong sell" rating.
1/30
07:00 am
qncx
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Citizens Jmp from an "outperform" rating to a "market perform" rating.
High
Report
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Citizens Jmp from an "outperform" rating to a "market perform" rating.
1/29
10:01 pm
qncx
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Citigroup Inc. from a "market outperform" rating to a "market perform" rating.
High
Report
Quince Therapeutics (NASDAQ:QNCX) was downgraded by analysts at Citigroup Inc. from a "market outperform" rating to a "market perform" rating.
1/12
11:40 am
qncx
Quince Therapeutics: Good Potential In Orphan Disease In Q1 With Platform Potential [Seeking Alpha]
High
Report
Quince Therapeutics: Good Potential In Orphan Disease In Q1 With Platform Potential [Seeking Alpha]
1/6
08:02 am
qncx
Quince Therapeutics (NASDAQ:QNCX) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Quince Therapeutics (NASDAQ:QNCX) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
12/30
04:14 pm
qncx
Quince Therapeutics (NASDAQ:QNCX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Quince Therapeutics (NASDAQ:QNCX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.